Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Jan 20;10(1):11-12.
doi: 10.18632/aging.101371.

Targeting LSD2 in breast cancer

Yi Huang  1   2 , Yongmei Yin  3 , Min Sun  1   4
Affiliations
Comment

Targeting LSD2 in breast cancer

Yi Huang et al. Aging (Albany NY). .
No abstract available

Keywords: LSD1; LSD2; breast cancer; cancer stem cell; small molecule inhibitor; target therapy; tumorigenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure and function of LSD1 and LSD2. (A) Structure and domain organization of LSD1 and LSD2 proteins. Lysine 661 (K661) and lysine 666 (K666) are FAD binding sites for LSD1 and LSD2. Zf-CW, zinc finger CW domain. SWIRM, Swi3p, Rsc8p and Moira domain. (B) Factors that interact with LSD1 or LSD2.
See this image and copyright information in PMC

Comment on

  • Epigenetics in breast cancer: what's new?
    Huang Y, Nayak S, Jankowitz R, Davidson NE, Oesterreich S. Huang Y, et al. Breast Cancer Res. 2011;13(6):225. doi: 10.1186/bcr2925. Epub 2011 Nov 1. Breast Cancer Res. 2011. PMID: 22078060 Free PMC article. Review.

References

    1. Højfeldt JW, et al. Nat Rev Drug Discov. 2013; 12:917–30. 10.1038/nrd4154 - DOI - PubMed
    1. Shi Y. Nat Rev Genet. 2007; 8:829–33. 10.1038/nrg2218 - DOI - PubMed
    1. Huang Y, et al. Breast Cancer Res. 2011; 13:225. 10.1186/bcr2925 - DOI - PMC - PubMed
    1. Cao C, et al. Oncogene. 2017; 36:133–45. 10.1038/onc.2016.186 - DOI - PMC - PubMed
    1. Chen L, et al. Oncotarget. 2017; 8:81737–53. 10.18632/oncotarget.19387 - DOI - PMC - PubMed

Substances